BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32657243)

  • 21. Refractory anemia with ring sideroblasts and RARS with thrombocytosis.
    Patnaik MM; Tefferi A
    Am J Hematol; 2015 Jun; 90(6):549-59. PubMed ID: 25899435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Concurrent CALR and SF3B1 gene mutations in a patient with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis].
    Nakao K; Oka S; Utsumi T; Yamada S; Kondo T; Tohyama K; Asagoe K
    Rinsho Ketsueki; 2019; 60(8):915-919. PubMed ID: 31484889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Splicing factor mutations in MDS RARS and MDS/MPN-RS-T.
    Yoshimi A; Abdel-Wahab O
    Int J Hematol; 2017 Jun; 105(6):720-731. PubMed ID: 28466384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Refractory anemia with ring sideroblasts.
    Malcovati L; Cazzola M
    Best Pract Res Clin Haematol; 2013 Dec; 26(4):377-85. PubMed ID: 24507814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1.
    Ok CY; Trowell KT; Parker KG; Moser K; Weinberg OK; Rogers HJ; Reichard KK; George TI; Hsi ED; Bueso-Ramos CE; Tam W; Orazi A; Bagg A; Arber DA; Hasserjian RP; Wang SA
    Mod Pathol; 2021 Jan; 34(1):20-31. PubMed ID: 32694616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): More than just a "catch-all" term?
    Shallis RM; Zeidan AM
    Best Pract Res Clin Haematol; 2020 Jun; 33(2):101132. PubMed ID: 32460977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomics of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.
    Patnaik MM; Lasho TL
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):450-459. PubMed ID: 33275756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.
    Patnaik MM; Tefferi A
    Am J Hematol; 2023 Apr; 98(4):681-689. PubMed ID: 36601682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological and molecular features of SF3B1-mutated myeloproliferative neoplasms.
    Boiocchi L; Hasserjian RP; Pozdnyakova O; Wong WJ; Lennerz JK; Le LP; Dias-Santagata D; Iafrate AJ; Hobbs GS; Nardi V
    Hum Pathol; 2019 Apr; 86():1-11. PubMed ID: 30594750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting survival in patients with myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis.
    Li F; Qin T; Li B; Qu S; Pan L; Zhang P; Sun Q; Cai W; Gao Q; Jiao M; Li J; Ai X; Ma J; Gale RP; Xu Z; Xiao Z
    Leukemia; 2024 Jun; 38(6):1334-1341. PubMed ID: 38714876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathologic characterisation of myeloid neoplasms with concurrent spliceosome mutations and myeloproliferative-neoplasm-associated mutations.
    Liu YC; Illar GM; Bailey NG
    J Clin Pathol; 2020 Nov; 73(11):728-736. PubMed ID: 32217616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Many faces of SF3B1-mutated myeloid neoplasms: concurrent mutational profiles contribute to the diverse clinical and morphologic features.
    Aqil B; Sukhanova M; Behdad A; Jennings L; Lu X; Chen Q; Chen YH; Gao J
    Hum Pathol; 2022 Nov; 129():81-89. PubMed ID: 36087739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
    Malcovati L; Papaemmanuil E; Bowen DT; Boultwood J; Della Porta MG; Pascutto C; Travaglino E; Groves MJ; Godfrey AL; Ambaglio I; Gallì A; Da Vià MC; Conte S; Tauro S; Keenan N; Hyslop A; Hinton J; Mudie LJ; Wainscoat JS; Futreal PA; Stratton MR; Campbell PJ; Hellström-Lindberg E; Cazzola M;
    Blood; 2011 Dec; 118(24):6239-46. PubMed ID: 21998214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencing.
    Patnaik MM; Lasho TL; Finke CM; Hanson CA; King RL; Ketterling RP; Gangat N; Tefferi A
    Am J Hematol; 2016 May; 91(5):492-8. PubMed ID: 26874914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to erythropoiesis-stimulating agents in patients with WHO-defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T).
    Antelo G; Mangaonkar AA; Coltro G; Buradkar A; Lasho TL; Finke C; Carr R; Binder M; Gangat N; Al-Kali A; Elliott MA; King RL; Howard M; Melody ME; Hogan W; Litzow MR; Tefferi A; Fernandez-Zapico ME; Komrokji R; Patnaik MM
    Br J Haematol; 2020 May; 189(3):e104-e108. PubMed ID: 32128785
    [No Abstract]   [Full Text] [Related]  

  • 36. A case of MDS/MPN overlap syndrome with ring sideroblasts and thrombocytosis: Tackling the quandary of thrombosis versus hemorrhage.
    Cherniawsky H; Razavi HM
    Clin Case Rep; 2023 Jun; 11(6):e7409. PubMed ID: 37260615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges in Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN).
    Smith BN; Savona M; Komrokji RS
    Clin Lymphoma Myeloma Leuk; 2019 Jan; 19(1):1-8. PubMed ID: 30555034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Refractory anemia with ring sideroblasts associated with marked thrombocytosis: a mixed group exhibiting a spectrum of morphologic findings.
    Gurevich I; Luthra R; Konoplev SN; Yin CC; Medeiros LJ; Lin P
    Am J Clin Pathol; 2011 Mar; 135(3):398-403. PubMed ID: 21350094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow ring sideroblasts in hematological diseases: an analysis of consecutive 1300 samples in a single institution.
    Hayama K; Abe Y; Kamata H; Okina S; Murakami Y; Kanoh Y; Suzuki T
    Int J Hematol; 2022 Apr; 115(4):508-514. PubMed ID: 35064465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis with co-mutated JAK2 and SF3B1.
    Reinig EF; He R
    Blood; 2017 Feb; 129(5):656. PubMed ID: 28153838
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.